Cargando…
Protease inhibitors as a potential agent against visceral Leishmaniasis: A review to inspire future study
Leishmaniasis is transmitted by sandfly which carries the intracellular protozoa in their midgut. Among visceral, cutaneous and mucocutaneous leishmaniasis, visceral type that is caused by Leishmania donovani is the most lethal one. Findings of leishmanial structure and species took place in 19(th)...
Autores principales: | Sreedharan, Veena, Rao, K.V. Bhaskara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871078/ https://www.ncbi.nlm.nih.gov/pubmed/36603827 http://dx.doi.org/10.1016/j.bjid.2022.102739 |
Ejemplares similares
-
Current Visceral Leishmaniasis Research: A Research Review to Inspire Future Study
por: Bi, Kaiming, et al.
Publicado: (2018) -
Development of Vaccines against Visceral Leishmaniasis
por: Evans, Krystal J., et al.
Publicado: (2012) -
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis
por: Freitas, Camila S., et al.
Publicado: (2020) -
Protease Inhibitors from Marine Actinobacteria as a Potential Source for Antimalarial Compound
por: Karthik, L., et al.
Publicado: (2014) -
Screening and identification of potential inhibitor for visceral leishmaniasis (VL) through computational analysis
por: Shaslinah, N., et al.
Publicado: (2022)